1. Home
  2. CTKB vs ZVRA Comparison

CTKB vs ZVRA Comparison

Compare CTKB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • ZVRA
  • Stock Information
  • Founded
  • CTKB 1990
  • ZVRA 2006
  • Country
  • CTKB United States
  • ZVRA United States
  • Employees
  • CTKB N/A
  • ZVRA N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTKB Health Care
  • ZVRA Health Care
  • Exchange
  • CTKB Nasdaq
  • ZVRA Nasdaq
  • Market Cap
  • CTKB 430.6M
  • ZVRA 481.7M
  • IPO Year
  • CTKB 2021
  • ZVRA 2015
  • Fundamental
  • Price
  • CTKB $3.69
  • ZVRA $11.23
  • Analyst Decision
  • CTKB Hold
  • ZVRA Strong Buy
  • Analyst Count
  • CTKB 4
  • ZVRA 9
  • Target Price
  • CTKB $6.00
  • ZVRA $23.25
  • AVG Volume (30 Days)
  • CTKB 960.6K
  • ZVRA 1.4M
  • Earning Date
  • CTKB 08-05-2025
  • ZVRA 08-12-2025
  • Dividend Yield
  • CTKB N/A
  • ZVRA N/A
  • EPS Growth
  • CTKB N/A
  • ZVRA N/A
  • EPS
  • CTKB N/A
  • ZVRA N/A
  • Revenue
  • CTKB $197,050,000.00
  • ZVRA $40,588,000.00
  • Revenue This Year
  • CTKB $0.91
  • ZVRA $303.00
  • Revenue Next Year
  • CTKB $7.75
  • ZVRA $78.29
  • P/E Ratio
  • CTKB N/A
  • ZVRA N/A
  • Revenue Growth
  • CTKB N/A
  • ZVRA 46.47
  • 52 Week Low
  • CTKB $2.37
  • ZVRA $5.45
  • 52 Week High
  • CTKB $7.63
  • ZVRA $13.16
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 60.88
  • ZVRA 53.62
  • Support Level
  • CTKB $3.20
  • ZVRA $11.49
  • Resistance Level
  • CTKB $3.44
  • ZVRA $11.95
  • Average True Range (ATR)
  • CTKB 0.18
  • ZVRA 0.54
  • MACD
  • CTKB 0.01
  • ZVRA -0.15
  • Stochastic Oscillator
  • CTKB 96.77
  • ZVRA 8.10

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: